Results 141 to 150 of about 23,173 (263)

Integrated Approach for the Discovery of Antifungal and Antibiofilm Agents From Cerrado Plants

open access: yesChemistry &Biodiversity, Volume 23, Issue 7, July 2026.
A comprehensive screening of 108 Brazilian Cerrado plant extracts identified potent inhibitors of Candida albicans biofilm formation. Active samples underwent UPLC–MS/MS and molecular networking for compound annotation, followed by in silico docking. This integrated workflow accelerates the discovery of bioactive metabolites by combining experimental ...
Lorena C. Albernaz   +7 more
wiley   +1 more source

Antifungal Activity and Possible Mechanism of Action of the Zn (II) Complex With a Schiff Base Against Fluconazole‐Resistant Strains of Candida spp. and Cryptococcus neoformans

open access: yesChemistry &Biodiversity, Volume 23, Issue 7, July 2026.
Addressing the global challenge of antifungal resistance, this work presents a vanillin‐derived Schiff base complexed with zinc (II) (SBZ) with potent activity against fluconazole‐resistant Candida spp. and Cryptococcus neoformans. By activating an apoptotic pathway, ranging from mitochondrial depolarization and oxidative stress to fungal DNA ...
Lívia Gurgel do Amaral Valente Sá   +14 more
wiley   +1 more source

Pulmonary Aspergillus Nodule in an Immunocompetent Host: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Aspergillus is a common fungal pathogen that typically causes severe infections in patients with compromised immunity. This report explores a rare case of a pulmonary Aspergillus nodule in an immunocompetent person without underlying conditions. A 52‐year‐old man initially presented for evaluation of his son's allergic rhinitis, during which a
Ahmad Alikhani   +4 more
wiley   +1 more source

Combination Antifungal Therapy and Formulary Optimization for Progressive Invasive Pulmonary Aspergillosis in a Pediatric Patient With Acute Myeloid Leukemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Therapeutic response in refractory invasive pulmonary aspergillosis may depend not only on antifungal class escalation, but also on formulation choice. In this complex pediatric acute myeloid leukemia (AML) case, radiologic improvement followed combination therapy and switch to brand‐name liposomal amphotericin B, underscoring the importance ...
Faryal Khamis   +3 more
wiley   +1 more source

One‐Pot Synthesis of 2‐Arylthio‐2‐Thiazolines via a Propargylamine Cyclization—Chan‐Lam C─S Arylation Strategy

open access: yesChemCatChem, Volume 18, Issue 14, 29 July 2026.
A concise, one‐pot route to 2‐arylthio‐2‐thiazolines uses propargylamine–CS2 cyclization, followed by copper‐catalyzed Chan‐Lam C─S arylation in 2‐MeTHF under O2, employing diverse propargylamines and arylboronic acids, avoiding thiazolidine‐2‐thione isolation. Stoichiometric studies provide insights into the arylation step mechanism.
Savvas G. Chalkidis   +1 more
wiley   +1 more source

Antifungal Potential of Cumin Spice Seeds, Cuminum cyminum, Against Aspergillus fumigatus: Mechanistic Insights Into Ergosterol, Melanin, and Biofilm Inhibition

open access: yesFood Frontiers, Volume 7, Issue 4, July 2026.
Antifungal effects and underlying mechanism of the action of the supercritical fluid extracted from the cumin (Cuminum cyminum) seeds and its volatile phyto‐constituents against pathogenic Aspergillus fumigatus. ABSTRACT Spices are aromatic culinary ingredients used worldwide for enhancing food flavors, folklore therapy, and their antiseptic ...
Acharya Balkrishna   +7 more
wiley   +1 more source

A compendium of extracellular vesicle biogenesis inhibitors: From bench to bedside

open access: yesInterdisciplinary Medicine, Volume 4, Issue 4, July 2026.
This review explores a decade of research on extracellular vesicles (EVs), detailing their biogenesis and roles in health and disease. It emphasizes EVs' relevance for potential medical applications covering various conditions such as cancer, neurodegeneration, inflammation, and infectious diseases, bridging experimental findings with clinical ...
Stefano Vecchione   +2 more
wiley   +1 more source

Accelerating Pediatric Oncology Drug Development: Advances in Clinical Pharmacology, Trial Design, Non‐Clinical Evidence, and Regulatory Science

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 7, July 2026.
Abstract Pediatric oncology drug development remains uniquely challenging due to the rarity and biological heterogeneity of childhood cancers, ethical considerations in trial conduct, and the limited feasibility of large, randomized studies. Despite these barriers, recent years have seen a notable acceleration in the approval of oncology therapies for ...
Ya‐Feng Wen   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy